Serum Protein Signatures for Breast Cancer Detection in Treatment-Naïve African American Women Using Integrated Proteomics and Pattern Analysis
Open Access
Abstract
Breast cancer is the leading cause of cancer-related mortality in African American (AA) women. In this study we evaluated the serum proteomic profile of AA women with breast cancer using an integrated proteomic framework with multivariate pattern analysis. Using 2D-DIGE, thousands of serum protein spots were detected across 33 gels; 46 spots met criteria for presence, statistical significance, and differential expression. Proteins from the spots were identified by MALDI-TOF/TOF and matched in curated databases, highlighting serum biomarkers including ceruloplasmin, alpha-2-macroglobulin, complement component C3 and C6, alpha-1-antitrypsin, alpha-1B-glycoprotein, alpha-2-HS-glycoprotein and haptoglobin-related protein. LC–MS/MS analysis revealed 163 differentiating peptides after imputing and filtering 286 peptides. These were evaluated using cumulative distribution function (CDF) analysis, a nonparametric method suited for limited sample sizes. Peptide patterns were explored with Random Forest, showing concordance with CDF. The model achieved an AUC of 0.85 at the peptide level. This workflow identified differentiating proteins (CERU, A2MG, CO3, VTDB, HEMO, APOB, APOA4, CFAH, CO4A, AACT, K1C10, ITIH2, ITIH4), highlighting CERU, A2MG, and CO3 with overexpression and reproducible identification across platforms. We present an integrated, non-invasive serum protein biomarker signature panel specific to AA women, through reproducible proteomic sensor framework to support early detection and breast cancer prevention.Keywords
Funding Information
- Susan G. Komen (#POP0402571)
This publication has 50 references indexed in Scilit:
- The Strategy for Peptidomic LC-MS/MS Data Analysis: The Case of Urinary Peptidome Study2024
- Breast cancer diagnosis: A systematic reviewBiocybernetics and Biomedical Engineering, 2024
- Progress and challenges of immunotherapy in triple-negative breast cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021
- Circulating lipids and breast cancer prognosis in the Malmö diet and cancer studyBreast Cancer Research and Treatment, 2021
- Disparities in Genetic Testing and Care Among Black Women with Hereditary Breast CancerCurrent Breast Cancer Reports, 2020
- Race, Ethnicity, and the Diagnosis of Breast CancerJAMA, 2015
- Differences in Breast Cancer Stage at Diagnosis and Cancer-Specific Survival by Race and Ethnicity in the United StatesJAMA, 2015
- The absolute quantification of eight inter‐α‐trypsin inhibitor heavy chain 4 (ITIH4)‐derived peptides in serum from breast cancer patientsProteomics – Clinical Applications, 2010
- 2‐D DIGE and MALDI‐TOF‐MS analysis of the serum proteome in human osteosarcomaProteomics – Clinical Applications, 2007
- Serum ceruloplasmin as a diagnostic marker of cancerCancer Letters, 1997